Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-06-05

FDA Approved: ACETADOTE — Supplemental Application (Cumberland Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Cumberland Pharmaceuticals' supplemental application for Acetadote (acetylcysteine), updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETADOTE (Acetylcysteine)

Snippet

SUPPL AP for ACETADOTE (ACETYLCYSTEINE)